Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Refractory orthostatic hypotension in a patient with a spinal cord injury: Treatment with droxidopa

Refractory orthostatic hypotension in a patient with a spinal cord injury: Treatment with droxidopa

The Journal of Spinal Cord Medicine, 2018 · DOI: 10.1080/10790268.2016.1274093 · Published: January 1, 2018

Spinal Cord InjuryCardiovascular SciencePharmacology

Simple Explanation

Orthostatic hypotension (OH) is a common issue for those with spinal cord injuries, especially those with complete injuries above T6. This means their blood pressure drops when they stand up. This report discusses a 65-year-old man with a spinal cord injury who had severe OH that didn't respond to standard treatments. The doctors tried a medication called droxidopa, and it helped. Droxidopa is a drug that can increase blood pressure. In this case, it helped the patient's blood pressure rise and improved his symptoms related to OH, allowing him to progress in his rehabilitation.

Study Duration
Not specified
Participants
A 65-year-old male with a grade ASIA A post-traumatic cervical spinal cord injury
Evidence Level
Level 4, Case Report

Key Findings

  • 1
    Droxidopa increased blood pressure levels in the patient, specifically a 10 mm Hg increase in systolic BP and 6 mm Hg in diastolic BP in the supine position.
  • 2
    The patient reported a subjective improvement in symptoms such as fatigue and cognitive function after starting droxidopa, with only occasional dizziness upon rising.
  • 3
    The patient did not experience significant side effects such as hypertension in a supine position or an increased heart rate while taking droxidopa.

Research Summary

This case report describes the successful use of droxidopa in a patient with a spinal cord injury who had refractory orthostatic hypotension (OH) that was not responding to standard treatments. The patient, a 65-year-old male with a C4 spinal cord injury, experienced significant improvement in symptoms and increased blood pressure levels after being treated with increasing doses of droxidopa. The authors conclude that droxidopa can be an effective alternative treatment for OH in patients with spinal cord injuries who do not respond to standard physical and pharmacological measures.

Practical Implications

Treatment Alternative

Droxidopa can be considered as an alternative treatment for patients with spinal cord injuries experiencing refractory OH when standard treatments are ineffective.

Individualized Dosing

The dosage of droxidopa should be individualized based on patient response and tolerance, as not all patients may respond to the same extent.

Further Research Needed

Long-term studies with a larger number of patients are necessary to determine the persistence of the effects of droxidopa and when to discontinue treatment.

Study Limitations

  • 1
    Single case report limits generalizability
  • 2
    Lack of long-term data on droxidopa use in this population
  • 3
    Potential for varying responses among patients

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury